Belder-Carr; Suzette

Patent Applications and Registrations

Patent applications and USPTO patent grants for Belder-Carr; Suzette.The latest application filed is for "methods for treating scleroderma by administering a soluble ctla4 molecule".

Company Profile

0.4.4

Belder-Carr; Suzette - Hopewell NJ

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Methods for treating dermatomyositis or polymyositis by administering a soluble CTLA4 molecule Grant 10,052,360 - Cohen , et al. August 21, 2	2018-08-21
Methods For Treating Scleroderma By Administering A Soluble Ctla4 Molecule App 20160158318 - COHEN; Robert ; et al.	2016-06-09
Methods for treating scleroderma by administering a soluble CTLA4 molecule Grant 9,296,808 - Cohen , et al. March 29, 2	2016-03-29
Methods For Treating Scleroderma By Administering A Soluble Ctla4 Molecule App 20140286948 - COHEN; Robert ; et al.	2014-09-25
Methods for treating Sjogrens syndrome by administering a soluble CTLA4 molecule Grant 8,722,632 - Cohen , et al. May 13, 2	2014-05-13
Methods for treating juvenile rheumatoid arthritis by administering a soluble CTLA4 molecule Grant 8,703,718 - Cohen , et al. April 22, 2	2014-04-22
Methods For Treating Juvenile Rhumatoid Arthritis By Administering A Soluble Ctla4 Molecule App 20130251713 - COHEN; ROBERT ; et al.	2013-09-26
Methods For Treating Sjogrens Syndrome By Administering A Soluble Ctla4 Molecule App 20130230518 - COHEN; ROBERT ; et al.	2013-09-05

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.